The current methodologies of clinical heart transplantation limit the ischemic window to 4–6 h. Periods longer than this can induce dysfunction in the organ and can lead to increased patient morbidity and mortality. An alternative to the current methods of static cold storage (CS) is continuous hypothermic perfusion (CHP), where a hypothermic oxygenated crystalloid solution is mechanically perfused through the coronary arteries. This has been shown to preserve the function for up to 72 h, but the techniques have yet to be optimized. We have developed an apparatus and methodology for performing CHP on large mammalian hearts, followed by reanimation in our in vitro Langendorff apparatus (The Visible HeartTM). We are also investigating the utility of the cardioprotective agents docosahexaenoic acid and [D-Ala2, D-Leu5] enkephalin, both of which have shown cardioprotective effects in our laboratory, and we believe that their addition to the preservation solution can further extend the transplant window. A series of pilot studies has been performed to date, with modestly successful results. Hearts preserved with CHP seem to show better functionality than CS hearts but far worse functionality than hearts reanimated immediately after explant. We hope to use this system to optimize CHP methodology and eventually develop a system for prolonging the window for heart transplantation.
Skip Nav Destination
Article navigation
Design Of Medical Devices Conference Abstracts
A Device and Methodology for Continuous Hypothermic Perfusion of Explanted Large Mammalian Hearts, Followed by In Vitro Langendorff Reanimation: Pilot Studies
Christopher D. Rolfes,
Christopher D. Rolfes
University of Minnesota
Search for other works by this author on:
Stephen A. Howard,
Stephen A. Howard
University of Minnesota
Search for other works by this author on:
Michael G. Bateman,
Michael G. Bateman
University of Minnesota
Search for other works by this author on:
Paul A. Iaizzo
Paul A. Iaizzo
University of Minnesota
Search for other works by this author on:
Robin M. Brusen
University of Minnesota
Christopher D. Rolfes
University of Minnesota
Stephen A. Howard
University of Minnesota
Michael G. Bateman
University of Minnesota
Paul A. Iaizzo
University of Minnesota
J. Med. Devices. Jun 2010, 4(2): 027530 (1 pages)
Published Online: August 11, 2010
Article history
Published:
August 11, 2010
Citation
Brusen, R. M., Rolfes, C. D., Howard, S. A., Bateman, M. G., and Iaizzo, P. A. (August 11, 2010). "A Device and Methodology for Continuous Hypothermic Perfusion of Explanted Large Mammalian Hearts, Followed by In Vitro Langendorff Reanimation: Pilot Studies." ASME. J. Med. Devices. June 2010; 4(2): 027530. https://doi.org/10.1115/1.3443733
Download citation file:
567
Views
Get Email Alerts
Cited By
Validation of a Repurposed pH Monitoring Capsule for Cecal Applications Using Novel Synthetic Cecal Contents
J. Med. Devices (March 2025)
Related Articles
Visualization of Coronary Artery Bypass Grafts and Coronary Artery Stents in Re-Animated and Perfusion Fixed Human Hearts
J. Med. Devices (June,2009)
The Evolution of the External Left Ventricular Assist Device
J. Med. Devices (June,2010)
Differential Translocation of Nuclear Factor-KappaB in a Cardiac Muscle Cell Line Under Gravitational Changes
J Biomech Eng (June,2009)
Design Optimization of Single-Port Minimally Invasive Intervention Devices
J. Med. Devices (June,2009)
Related Proceedings Papers
Related Chapters
Introduction
Modified Detrended Fluctuation Analysis (mDFA)
Micromachined 1-3 Composite Single Element Transducers
High Frequency Piezo-Composite Micromachined Ultrasound Transducer Array Technology for Biomedical Imaging
Computer-Aided Screening Program Management in Audiology and Cardiology
International Conference on Measurement and Control Engineering 2nd (ICMCE 2011)